SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 15, 2003
Commission File Number: 000-49620
Biogentech Corporation
----------------------
(Exact name of registrant as specified in its charter)
Nevada 91-1868007
------ ----------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
2445 McCabe Way, Suite 150, Irvine, California 92614
---------------------------------------------- -----
(Address of principal executive offices) (Zip Code)
(949) 757-0001
--------------
(Registrant's Telephone Number, Including Area Code)
1
Item 8. CHANGE IN FISCAL YEAR
On July 15, 2003, the Registrant's Board of Directors approved a change in the
Registrant's fiscal year end from December 31st to March 31st. The Registrant's
next fiscal year will begin on April 1st and end on March 31st of each year,
effective with the year beginning April 1, 2004.
Reference is made to the audited financial reports for the years ending March
31, 2003 and March 31, 2002 for Biogentec, Inc. which were filed with the
Registrant's report on Form 8-K on July 1, 2003 as amended, regarding the
Registrant's subsidiary's acquisition of Biogentec, Inc. and other events. The
Registrant expects to file Quarterly Reports on Form 10-Q on or before the due
dates of August 14, 2003, November 15, 2003 and February 28, 2004, and to file
its next Annual Report on Form 10-K on or before June 30, 2004.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Biogentech Corp.
July 15, 2003 By: /s/ Chaslav Radovich
--------------------------------
Chaslav Radovich, President